Patent Yard Sign in
Expired Canadian patentCanada

Protein-protein interactions in human immunodeficiency virus

CA 2468326 C · Owner: Rain, Jean-Christophe · Inventors: Blot, Guillaume; Emiliani, Stephane; Berlioz-Torrent, Clarisse

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention relates to protein-protein interactions involved in AIDS. More specifically, the present invention relates to complexes of polypeptides or polynucleotides encoding the polypeptides fragments of the , polypeptides, antibodies to the complexes selected Interacting Domains , (SID®) which are identified due to the protein-protein interactions methods for screening drugs of agents which modulate the interaction of proteins and pharmaceutical compositions that are capable of modulating the protein-protein interactions.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed November 26, 2002 and granted November 17, 2015. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 26, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 26, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledNovember 26, 2002
GrantedNovember 17, 2015
Term endedNovember 26, 2022
Patent numberCA 2468326 C
Classification (IPC)C12N15/48 +2 more

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedNov 26, 2002Patent grantedNov 17, 2015Term endedNov 26, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.